HOMEPRODUCTSSERVICESCOMPANYCONTACTFAQResearchDictionaryPharmaMobileSign Up FREE or Login

Cheng-Chia Yu Selected Research

aldehyde dehydrogenase 1

9/2015Activation of microRNA-494-targeting Bmi1 and ADAM10 by silibinin ablates cancer stemness and predicts favourable prognostic value in head and neck squamous cell carcinomas.
6/2013miR145 targets the SOX9/ADAM17 axis to inhibit tumor-initiating cells and IL-6-mediated paracrine effects in head and neck cancer.
3/2013Quercetin in elimination of tumor initiating stem-like and mesenchymal transformation property in head and neck cancer.
8/2012Impairment of tumor-initiating stem-like property and reversal of epithelial-mesenchymal transdifferentiation in head and neck cancer by resveratrol treatment.
3/2011MicroRNA let-7a represses chemoresistance and tumourigenicity in head and neck cancer via stem-like properties ablation.
1/2011Bmi-1 Regulates Snail Expression and Promotes Metastasis Ability in Head and Neck Squamous Cancer-Derived ALDH1 Positive Cells.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research network!


Choose Username:
Email:
Password:
Verify Password:


Cheng-Chia Yu Research Topics

Disease

20Neoplasms (Cancer)
09/2015 - 01/2010
10Squamous Cell Carcinoma (Epidermoid Carcinoma)
09/2015 - 01/2010
6Neoplasm Metastasis (Metastasis)
12/2014 - 01/2010
6Head and Neck Neoplasms (Head and Neck Cancer)
01/2014 - 01/2010
5Tics (Tic)
09/2015 - 03/2012
3Mouth Neoplasms (Oral Cancer)
06/2013 - 09/2011
2Infection
10/2015 - 01/2013
1Gingival Overgrowth
01/2015
1Anoxia (Hypoxia)
01/2015
1Inflammation
12/2014
1Oral Submucous Fibrosis
01/2013
1Liver Neoplasms (Liver Cancer)
01/2013
1Lung Neoplasms (Lung Cancer)
04/2012
1Glioblastoma (Glioblastoma Multiforme)
03/2012
1Astrocytoma (Pilocytic Astrocytoma)
03/2012
1Teratoma (Teratoid Tumor)
01/2012
1Breast Neoplasms (Breast Cancer)
11/2011

Drug/Important Bio-Agent (IBA)

6aldehyde dehydrogenase 1IBA
09/2015 - 01/2011
3Arecoline (Arecolin)IBA
10/2015 - 01/2013
3Carbon MonoxideIBA
09/2015 - 11/2011
3Transcription Factors (Transcription Factor)IBA
01/2014 - 01/2013
3MicroRNAs (MicroRNA)IBA
04/2012 - 01/2010
2resveratrolIBA
08/2012 - 03/2012
2Polyurethanes (Polyurethane)IBA
05/2012 - 04/2012
1silybin (silibinin)IBA
09/2015
1Plasminogen Activator Inhibitor 1IBA
01/2015
1Cyclosporine (Ciclosporin)FDA LinkGeneric
01/2015
1Plasminogen Activators (Plasminogen Activator)IBA
01/2015
1BerberineIBA
12/2014
11-phenyl-3,3-dimethyltriazene (PDT)IBA
01/2014
1thymoquinoneIBA
01/2014
1beta-thujaplicinIBA
06/2013
1Interleukin-6 (Interleukin 6)IBA
06/2013
1InterleukinsIBA
06/2013
1Conditioned Culture MediaIBA
06/2013
1CytokinesIBA
06/2013
1CurcuminIBA
06/2013
1Cadherins (E-Cadherin)IBA
03/2013
1QuercetinIBA
03/2013
1VimentinIBA
03/2013
1Protein-Lysine 6-Oxidase (Lysyl Oxidase)IBA
02/2013
1NicotineFDA Link
02/2013
1Reactive Oxygen Species (Oxygen Radicals)IBA
01/2013
1CollagenIBA
01/2013
1ergostaneIBA
01/2013
1nestin (nestin protein)IBA
08/2012
1Nuclear Localization Signals (Nuclear Localization Signal)IBA
05/2012
1Small Interfering RNA (siRNA)IBA
05/2012
1DNA (Deoxyribonucleic Acid)IBA
05/2012
1Adenocarcinoma of lungIBA
04/2012
1alpha- cyano- (3,4- dihydroxy)- N- benzylcinnamideIBA
03/2012
1Messenger RNA (mRNA)IBA
01/2012
1Biological Markers (Surrogate Marker)IBA
11/2011
1HSP70 Heat-Shock Proteins (Heat-Shock Protein 70)IBA
11/2011
1Cisplatin (Platino)FDA LinkGeneric
09/2011
1Glucose (Dextrose)FDA LinkGeneric
01/2010

Therapy/Procedure

9Heterologous Transplantation (Xenotransplantation)
09/2015 - 01/2010
2Therapeutics
03/2013 - 08/2012
1Photochemotherapy (Photodynamic Therapy)
01/2014
1Drug Therapy (Chemotherapy)
08/2012
1Radiotherapy
03/2012
1Transplants (Transplant)
01/2012
1Transplantation (Transplant Recipients)
01/2012